» Articles » PMID: 12668795

Risk Factors Associated with the Presence of Irreversible Airflow Limitation and Reduced Transfer Coefficient in Patients with Asthma After 26 Years of Follow Up

Overview
Journal Thorax
Date 2003 Apr 2
PMID 12668795
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Childhood asthma is generally believed to be a disorder with a good prognosis. However, some asthmatics develop irreversible airway obstruction, probably as a result of airway remodelling.

Methods: After 21-33 years, 228 adults (aged 13-44 years at baseline) with a history of asthma were re-examined to assess risk factors for the development of irreversible airway obstruction (IAO, forced expiratory volume in 1 second (FEV(1)) <80% predicted and reversibility <9% predicted) and a reduced postbronchodilator transfer coefficient (carbon monoxide transfer factor/alveolar volume, <80% predicted), both characteristics of COPD.

Results: At follow up, 41% did not have airway obstruction (NAO), 43% had reversible airway obstruction (RAO), and 16% had IAO; 23% had a reduced transfer coefficient. Patients with RAO had asthma-like characteristics (wheezing, asthma attacks, bronchial hyperresponsiveness (BHR)) while patients with IAO had COPD-like symptoms (cough, phlegm, dyspnoea) at follow up. The development of IAO is determined by a lower FEV(1), less reversibility of airway obstruction and, surprisingly, less severe BHR at initial screening. Eighty percent of the patients with asthma who used anti-inflammatory medication still had airway obstruction, but IAO developed less frequently. Smoking was associated with a reduced transfer coefficient but not with the development of IAO. Female sex was associated with a reduced transfer coefficient, whereas corticosteroid use was not.

Conclusions: Although IAO and a low transfer coefficient are both characteristics of COPD, they represent distinct entities in adult asthmatics in terms of symptomatology, aetiology, and probably in therapeutic approaches and disease prevention.

Citing Articles

Clinico-spirometrical correlation of newly detected COPD patients with known tobacco smoking exposure or biomass smoke exposure presenting to a teaching institution in Vadodara, Gujarat.

Patel B, Mothiganesh G, Shah A, Chakravarti C, Naik P, Patel P J Family Med Prim Care. 2025; 14(1):97-100.

PMID: 39989552 PMC: 11844980. DOI: 10.4103/jfmpc.jfmpc_836_24.


Evaluation of the prevalence of asthma and chronic obstructive pulmonary disease among opium users, and cigarette smokers and comparison with normal population in Kharameh: a cross-sectional study.

Raeisy L, Masoompour S, Rezaianzadeh A BMC Pulm Med. 2023; 23(1):419.

PMID: 37914995 PMC: 10619218. DOI: 10.1186/s12890-023-02734-8.


Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study.

Menzies-Gow A, Ambrose C, Colice G, Hunter G, Cook B, Molfino N Adv Ther. 2023; 40(11):4957-4971.

PMID: 37723356 PMC: 10567907. DOI: 10.1007/s12325-023-02659-y.


Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design.

de Prado Gomez L, Pavord I, Busse W, Brightling C, Wechsler M, Rabe K ERJ Open Res. 2023; 9(2).

PMID: 36891077 PMC: 9986762. DOI: 10.1183/23120541.00417-2022.


Asthma and COPD Overlap Syndrome (ACOS): Risk Factors and Contributing Factors.

Esmaeilzadeh H, Nabvizadeh H, Gholami M, Yousefi M, Mortazavi N, Vali M Med J Islam Repub Iran. 2023; 36:151.

PMID: 36636259 PMC: 9826780. DOI: 10.47176/mjiri.36.151.


References
1.
Panhuysen C, Vonk J, Koeter G, Schouten J, van Altena R, Bleecker E . Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med. 1997; 155(4):1267-72. DOI: 10.1164/ajrccm.155.4.9105065. View

2.
Hudon C, Turcotte H, Laviolette M, Carrier G, Boulet L . Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol. 1997; 78(2):195-202. DOI: 10.1016/s1081-1206(10)63387-x. View

3.
Lange P, Parner J, Vestbo J, Schnohr P, Jensen G . A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998; 339(17):1194-200. DOI: 10.1056/NEJM199810223391703. View

4.
Roorda R . Childhood asthma: outcome after 20 years. Pediatr Pulmonol Suppl. 1999; 18:99-102. View

5.
BOOY-NOORD H, ORIE N, ten Cate H . The influence of various drugs on the vital capacity of asthmatics. Int Arch Allergy Appl Immunol. 1957; 10(6):321-41. DOI: 10.1159/000228391. View